TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Biobasiq Sverige AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
31,649
|
26,746
|
17,078 |
| Financial expenses |
55
|
46
|
55 |
| Earnings before taxes |
2,082
|
74
|
1,002 |
| EBITDA |
2,037
|
67
|
1,058 |
| Total assets |
9,929
|
8,004
|
6,960 |
| Current assets |
9,929
|
8,004
|
6,960 |
| Current liabilities |
2,757
|
2,582
|
1,949 |
| Equity capital |
7,173
|
5,422
|
5,011 |
| - share capital |
103
|
101
|
95 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
72.2%
|
67.7%
|
72.0% |
| Turnover per employee |
15,824
|
13,373
|
8,539 |
| Profit as a percentage of turnover |
6.6%
|
0.3%
|
5.9% |
| Return on assets (ROA) |
21.5%
|
1.5%
|
15.2% |
| Current ratio |
360.1%
|
310.0%
|
357.1% |
| Return on equity (ROE) |
29.0%
|
1.4%
|
20.0% |
| Change turnover |
4,421
|
8,457
|
1,861 |
| Change turnover % |
16%
|
46%
|
12% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.